A detailed history of Plimoth Trust CO LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Plimoth Trust CO LLC holds 3,834 shares of EW stock, worth $349,200. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,834
Previous 3,639 5.36%
Holding current value
$349,200
Previous $277,000 32.13%
% of portfolio
0.1%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$72.54 - $95.56 $14,145 - $18,634
195 Added 5.36%
3,834 $366,000
Q4 2023

Jan 26, 2024

SELL
$61.71 - $77.76 $13,576 - $17,107
-220 Reduced 5.7%
3,639 $277,000
Q3 2023

Oct 20, 2023

SELL
$69.28 - $93.38 $13,093 - $17,648
-189 Reduced 4.67%
3,859 $267,000
Q2 2023

Jul 21, 2023

SELL
$81.41 - $94.33 $2,035 - $2,358
-25 Reduced 0.61%
4,048 $381,000
Q1 2023

Apr 26, 2023

SELL
$74.26 - $84.51 $11,881 - $13,521
-160 Reduced 3.78%
4,073 $336,000
Q4 2022

Jan 19, 2023

BUY
$68.3 - $87.44 $289,113 - $370,133
4,233 New
4,233 $316,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $56.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Plimoth Trust CO LLC Portfolio

Follow Plimoth Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plimoth Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plimoth Trust CO LLC with notifications on news.